$LLY INSIGHTS →JPMorgan raised its price target on Eli Lilly (LLY) from $1,300 to $1,400, maintaining an Overweight rating and calling it its top healthcare pick.
Read the full research in the app
A subscription is required to access the full thread.
Open in the app →